APA (7th ed.) Citation

J, D. G., JC, Y., A, V., B, V., P, d. T., L, B., . . . L, B. (2025). Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study. The Journal of infectious diseases, 231(6), 1425. https://doi.org/10.1093/infdis/jiaf098

Chicago Style (17th ed.) Citation

J, De Greef, et al. "Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study." The Journal of Infectious Diseases 231, no. 6 (2025): 1425. https://doi.org/10.1093/infdis/jiaf098.

MLA (9th ed.) Citation

J, De Greef, et al. "Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study." The Journal of Infectious Diseases, vol. 231, no. 6, 2025, p. 1425, https://doi.org/10.1093/infdis/jiaf098.